Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1

Dev Med Child Neurol. 2011 Oct;53(10):962-4. doi: 10.1111/j.1469-8749.2011.04048.x. Epub 2011 Jul 11.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Belgium
  • Child
  • Child, Preschool
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / etiology
  • Cyclohexanones / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Intelligence / drug effects
  • Intelligence Tests
  • Male
  • Neuropsychological Tests*
  • Nitrobenzoates / therapeutic use*
  • Phenylalanine / blood
  • Treatment Outcome
  • Tyrosine / blood
  • Tyrosinemias / complications
  • Tyrosinemias / drug therapy*

Substances

  • Cyclohexanones
  • Enzyme Inhibitors
  • Nitrobenzoates
  • Tyrosine
  • Phenylalanine
  • nitisinone